UPL Limited
UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds.
What UPL files
- Others108
- Important42
- Investor Meet35
- Updates23
- PPTs9
- Dividend/Bonus8
UPL reported strong Q1 FY27 results: Revenue rose 10% YoY to ₹10,181 Cr, and EBITDA increased 15% YoY to ₹1,500 Cr. Net Debt was maintained at $2.5 Bn with improved gearing. The company guides for 7-11% full-year revenue and 10-14% EBITDA growth, focusing on value creation.
UPL has completed key internal swap transactions, advancing its scheme to consolidate global and India crop protection businesses under a single entity. This aims for a focused platform. Management expects no material financial impact on consolidated assets, liabilities, or profitability.
UPL has received "no adverse observations" from BSE and "No Objection" from NSE for its proposed corporate restructuring plan. This regulatory clearance allows UPL to proceed with filing the scheme with NCLT, a significant step in its multi-entity arrangement.
UPL delivered a record FY26, with revenue up 11% to ₹51,839 Cr. PBT surged 4x and operational PATMI >2.5x. Q4 revenue grew 18% to ₹18,335 Cr. The company significantly deleveraged, with Net Debt at $1.6 Bn and Net Debt/EBITDA at 1.6x.
UPL's Board approved a scheme to create two listed entities: a diversified UPL and a new pure-play crop protection platform, UPL Global. The demerged crop protection business has INR 2,412 Cr turnover (31% of total) and UPL Global will have ~28% public shareholding, aiming for sharper focus & value.